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ABSTRACT 
The K+ channel interacting proteins (KChIPs) are members of the neuronal calcium sensor 
protein family of Ca2+-binding proteins. It is unclear to what extent the KChIPs have 
distinct functions although they all interact with Kv4 K+ channels. KChIP3 has also been 
shown to repress transcription of specific genes via binding to DRE motifs and all KChIPs 
may share this function. We have compared the function of isoforms of the four KChIPs. 
KChIPs1-4 were found to stimulate the traffic of Kv4.2 channels to the plasma membrane.  
KChIP3 expression in PC12 cells resulted in an increase in exocytosis evoked by activation 
of purinergic receptors. In contrast, KChIPs1, 2 and 4, although expressed to the same 
extent, had no effect on secretion. In addition, KChIP3 but not KChIPs 1, 2 and 4 modified 
the ATP-induced Ca2+ signal resulting in a delay in recovery after the peak Ca2+ elevation 
and also specifically resulted in down regulation of the NCX3 Na/Ca2+ exchanger NCX3 
that could explain the effects on the Ca2+ signal and secretion. Regulation of NCX3 by 
KChIP3 has been shown to occur via its DREAM function (Gomez-Villafuertes et al. J 
Neurosci. (2005) 25, 10822-10830) suggesting that this activity might depend on the cellular 
context of expression of the various KChIPs. These results reveal a new role for KChIP3 in 
the regulation of Ca2+-regulated secretion and also suggest that the functions of each of the 
KChIPs may be more specialised than previously appreciated.
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INTRODUCTION 
The transduction of intracellular Ca2+ signals into physiological responses is mediated by 
Ca2+ sensor proteins that interact with specific target proteins to modify their function [1]. 
Many of these Ca2+ sensors bind Ca2+ via EF-hand domains. One such family of proteins 
are the neuronal calcium sensor (NCS) proteins consisting of NCS-1, neurocalcin δ, 
hippocalcin, VILIPs1-3, recoverin, GCAPs1-3 and the K+ channel interacting proteins 
(KChIPs)1-4 [2, 3]. Certain of the NCS proteins are expressed only in the retina (recoverin 
and GCAPs)[4], whereas others are expressed predominantly in the brain or in the case of 
NCS-1 in a wide range of neuronal and non-neuronal cell types. Mammals have at least 26 
different NCS proteins generated by expression of 14 genes and by differential splicing [5]. 
The distinct cellular expression patterns of the NCS proteins, their distinct cellular and 
molecular properties and in particular their specific target proteins, allows them to regulate 
a diverse range of neuronal functions in a non-redundant manner [2]. The latter point is 
supported by the presence of clear phenotypes in organisms with genetic disruption of the 
expression of only a single NCS protein  [2]. It is still unclear however, why so many 
different NCS proteins are required. 
 
In mammals, KChIP proteins are encoded by four genes (KChIPs1-4) each of which can 
give rise to multiple splice variants [5]. The KChIPs were so named based on their 
discovery as proteins that can interact with the pore forming subunits of potassium 
channels of the Kv4 family [6, 7] [8]. The physiological significance of KChIPs 2 and 3 in 
the heart and the brain has been established from study of mouse knock-outs [9-11]. All 
KChIP proteins examined so far are able to become constitutive subunits of Kv4 channels 
[12, 13], stimulate Kv4 channel traffic to the plasma membrane[14] [15] and modify the 
gating properties of the channels [6]. Different KChIPs or their isoforms have, however, 
subtly different effects on Kv4 channel gating properties [8, 16, 17]. KChIP3 was 
independently discovered in two other contexts. First, as calsenilin a protein able to interact 
with the presenilins and affect the processing of amyloid precursor protein [18]. Second, as 
downstream regulatory element antagonistic modulator (DREAM) based on its ability to 
act as a repressor of transcription when it is Ca2+-free but not Ca2+ -bound [19]. In addition, 
to the common interaction with Kv4 channels, isoforms of all four KChIPS have been 
shown to have DREAM activity [20] and at least KChIP4, in addition to KChIP3, can also 
interact with presenilins [7]. The KChIPs may not all have overlapping functions as knock-
out of KChIP2 and 3 leads to non-compensated phenotypes [9-11]. The non-redundancy 
may be due, however, to differential expression of KChIPs in different cell types. The 
requirement for multiple KChIPs may relate to specific neuronal expression patterns [21, 
22] allowing differences in fine tuning of Kv4 channel function, for example, in different 
neuronal cell types. Nevertheless, it is still unclear to what extent the KChIPs have fully 
overlapping or distinct functional roles. We have set out to compare the functions of 
representative isoforms of each of the four KChIPs and this has revealed a specific effect of 
KChIP3/calsenilin/DREAM in modifying agonist-evoked Ca2+ signals and in enhancing 
secretion from PC12 cells.  
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MATERIALS AND METHODS 
 
PLASMIDS 
Plasmid encoding presenilin-1-EGFP (PS-1-EGFP) [23] was a gift from Dr Christian 
Haass (Adolf-Butenandt-Institute, Department of Biochemistry, Ludwig-Maximilians-
University, Munich, Germany). The KChIP splice variants used in this study were 
KChIP1.2, KChIP2.3, KChIP3.1 and KChIP4.1 but these will be referred to henceforth as 
KChIP1-4.  All KChIP isoforms used are human, with the GenBank accession numbers as 
follows:  DQ148477 (1.2), DQ148481 (2.3), DQ148485 (3.1) and DQ148487 (4.1). The 
KChIP1-ECFP, ECFP-Kv4.2 plasmids were described previously [15, 24]. The KChIP2-
ECFP construct was made by inserting the KChIP2 sequence into the pECFP-N1 vector 
(Clontech, California, USA) following amplification from an existing KChIP2-pcDNA 
construct (kindly provided by Dr. Robert Bähring, Zentrum für Molekulare Neurobiologie, 
Hamburg, Germany) with the following primers (endonuclease sites underlined):  the sense 
primer was 5’-ACTCAGATCTCAGGATGCGGGGCCAGGGCCGC-3’ (BglII) and the 
antisense primer was 5’-TACCGTCGACTGGATGACATTGTCAAAGAG-3’ (SalI). The 
KChIP3-ECFP construct was made by inserting the KChIP3 sequence into the pECFP-N1 
vector following amplification from an existing KChIP3-EYFP construct with the 
following primers:  the sense primer used was 5’-
ACTCAGATCTCAGGATGCAGCCGGCTAAGGAA-3’ (BglII) and the antisense primer 
was 5’-TGCAGAATTCCGATGACATTCTCAAACAGC-3’ (EcoRI).  The KChIP4-ECFP 
construct was made by insertion of the KChIP4 sequence into the pECFP-N1 vector 
following amplification from a KChIP4 cDNA clone (OriGene, Rocksville, USA), with the 
following primers: the sense primer was 5’-
ACTCAGATCTCAGGATGAATGTGAGGAGGGTG-3’ (BglII) and the antisense primer 
was 5’-TACCGTCGACTGAATCACATTTTCAAAGAG-3’ (SalI). The pcDNA-KChIP3 
construct was made by the insertion of the KChIP3 sequence into the pcDNA3.1 (+) vector 
(Invitrogen), following amplification from KChIP3-EYFP with the following primers:  the 
sense primer used was 5’-TTCGAATTCAGGATGCAGCCGGCTAAGGAA-3’ (EcoRI) 
and the antisense primer was 5’-CAACGCGGCCGCTAGATGACATTCTCAAACAGC-
3’ (NotI). The FLAG tagged KChIP constructs were made by insertion into the pFLAG-
CMV-4 expression vector (Sigma, USA), following amplification from existing constructs.  
For FLAG-KChIP1, the sense primer was 5’-
GCTTGCGGCCGCGAGGATGGGGGCCGTCATGGGC-3’ (NotI) and the antisense 
primer was 5’-TATCAGATCTATTTACATGACATTTTGAAACAG-3’ (BglII). 
For FLAG-KChIP2, the sense primer used was 5’-
GCTTGCGGCCGCGAGGATGCGGGGCCAGGGCCGC-3’ (NotI) and the antisense 
primer was 5’-TATCAGATCTATCTAGATGACATTGACAAAGAG-3’ (BglII). 
For FLAG-KChIP3, the sense primer used was 5’-
GCTTGCGGCCGCGAGGATGCAGCCGGCTAAGGAA-3’ (NotI) and the antisense 
primer was 5’-TATCAGATCTCCCTAGATGACATTCTCAAACAGC-3’ (BglII).  For 
FLAG-KChIP4, the sense primer used was 5’-
GCTTGCGGCCGCGAGGATGAATGTGAGGGTG-3’ (NotI), and the antisense primer 
was 5’-TATCAGATCTATTTAAATCACATTTTCAAAGAG-3’ (BglII). 
All primers used in PCR amplification were produced by Genosys Biotechnologies 
(Cambs, UK) and the sequences of all the constructs were confirmed by sequencing by 
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DBS Genomics (Durham, UK). 
 
 
CULTURE AND TRANSFECTION OF HELA AND COS-7 CELLS 
HeLa and COS-7 cells were grown in  Dulbecco’s modified Eagle’s medium (Gibco, 
Paisley, UK) containing 5% foetal calf serum (Gibco, Paisley, UK) and 1% non-essential 
amino acids (Gibco, Paisley, UK) and maintained in 75cm2 flasks at 37oC in an atmosphere 
of 5% CO2.  At 16-24 hours prior to transfection, cells were seeded onto glass cover slips 
in a 24-well plate at 40,000 cells per well or 100,000 cells per well of a 6 well plate.  Cells 
were then transfected at approaching 50% confluency using 100µl transfection reaction 
mixture.  The transfection mix typically contained 1µg plasmid DNA (2µg for double 
transfections), 3µl (per µg plasmid DNA) Fugene (Roche, UK) and was made up to 100µl 
with Dulbecco’s modified Eagle’s medium (Gibco, Paisley, UK).  The transfection reaction 
mixture was incubated at room temperature for 30 minutes before being added drop-wise 
to the cells.  Cells were then maintained at 37oC for an additional 48 hours before being 
used in experiments. 
 
CULTURE AND TRANSFECTION OF PC12 CELLS 
PC12 cells were grown in suspension in RPMI 1640 media (Gibco, Paisley, UK) 
containing 5%foetal calf serum (Gibco, Paisley, UK), 10% horse serum (Gibco, Paisley, 
UK), 100 units/ml penicillin and 0.1mg/ml streptomycin (Sigma) at 37oC in an atmosphere 
of 5% CO2.  At 16-24 hours before transfection, freshly trypsinized cells were plated onto 
collagen-coated glass cover slips in a 24 well plate at a density of 200,000 cells/well or 
350,000 cells/well for larger coverslips.  Cells were then transfected using 100µl 
transfection reaction mixture consisting of 1µg plasmid DNA, 3µl LipofectAMINE 2000 
transfection reagent (Invitrogen, UK) per µg of plasmid DNA and made up to 100µl in 
opti-mem (Gibco, Paisley, UK)  The transfection mixture was incubated at room 
temperature for 30 minutes before being added drop wise to the cells.  The cells were then 
incubated for 4-6 hours at 37oC with the transfection reaction mixture before removing the 
transfection reaction mixture and replacing with growth media.  Cells were then 
maintained at 37oC, 5% CO2 for an additional 48 hours before being used in experiments. 
 
IMAGING OF CELLS AND IMUNOFLUORESCENCE STAINING  
For imaging of transfected cells expressing fluorescent constructs, the cells were washed 
twice in phosphate buffered saline (PBS): 137mM NaCl, 2.7mM KCl, 10mM Na2HPO4 , 
2mM NaH2PO4, and fixed in PBS containing 4% formaldehyde for 30 minutes.  Cells were 
then washed in PBS before air-drying the coverslips and mounted on glass slides using 
antifade Vectashield (Vector Laboratories Inc.). For immunostaining of cells attached to 
coverslips, these were washed twice in PBS before fixation in PBS containing 4% 
formaldehyde for 30 minutes.  The cells were incubated in PBT (PBS, 0.1% Triton X-100, 
0.3% BSA) for 30 min.  The PBT was removed, replaced by the primary antibody diluted 
in PBT and the coverslips incubated for 1-2 hours. For staining of Kv4.2 channels after 
transfection of COS7 cells, rabbit anti-Kv4.2 antiserum (Exalpha Biologicals Inc, Maynard 
MA, USA) was used at a 1:500 dilution.  For staining of endogenous NCX-2 and NCX-3 
proteins, PC12 cells were incubated with mouse monoclonal anti-NCX2 at 1:50 or rabbit 
polyclonal anti-NCX3 at1:50. Anti-NCX2 and NCX3 were a kind gift from Professor 
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Kenneth Philipson, (Cardiovascular Research Laboratories, UCLA School of Medicine, 
LA, CA, USA). The cells were washed three times in PBT followed by incubation with an 
appropriate species-specific Dylight-649 conjugated secondary antibody (1:200; Pierce, 
Cramlington, UK) for 30 min prior to air drying and mounting of coverslips onto glass 
slides. 
 
CONFOCAL LASER SCANNING MICROSCOPY 
For confocal laser scanning microscopy, either a Leica AOBS microscope system (Leica, 
Heidelberg, Germany) or a Leica TCS-SP-MP microscope was used to examine transfected 
cells using an optimal pin hole of 1 airy unit and a 63x water immersion objective with a 
1.2 numerical aperture.  For imaging of live cells, cells were maintained in Krebs-Ringer 
buffer (20mM HEPES (pH7.4), 145mM NaCl, 10mM glucose, 5mM KCl, 3mM CaCl2, 
1.3mM MgCl2, 1.2mM NaH2PO4). For imaging ECFP-tagged constructs, cells were excited 
at 430nm and light collected at 460-510nm.  EGFP was imaged using excitation at 488nm 
with collection at 500-550nm. . For dual imaging of ECFP tagged KChIP proteins and 
Kv4.2 or endogenous NCX proteins labelled with Dylight-649, cells were excited with 405 
nm and 633 nm lasers and light was collected at 465–500 nm (ECFP) and 680-750 nm 
(Dylight 649). Images were exported as Tiff files and compiled in CorelDraw. 
 
For quantification of total ECFP fluorescence or anti-NCX-2 and NCX-3 fluorescence 
staining in PC12 cells, Leica-Lite post-capture analysis software (Leica Microsystems, 
Heidelberg, Germany) was used to draw regions of interest around the perimeter of cells. 
The fluorescence intensity of anti-NCX2 or NCX3 staining in KChIP-ECFP expressing 
cells was directly compared to control non-transfected cells on the same coverslips. For 
comparison of expression levels of KChIP1-4, transfected cells were examined for all 
constructs on the same day using identical imaging conditions with the same settings for 
magnification, laser power and gain. 
 
WESTERN BLOTTING 
Cells to be used for Western blotting were washed in PBS followed by lysis in 100µl 
Laemmli buffer (Sigma).  Cell samples were then boiled for 10 minutes.  Typically 20µl of 
sample was separated on a 10% SDS gel before overnight transfer onto nitrocellulose.  
Nitrocellulose blots were washed twice with PBS for 15 minutes before blocking with 3% 
milk in PBS for 45 minutes.  The primary antibody was added at the appropriate dilution 
(anti-GFP at 1:5000) in 3% milk in PBS and incubated was added for 1 hour at room 
temperature or overnight at 4oC, then removed and the blot washed three times in PBS.  
The blot was then incubated with the appropriate HRP-conjugated secondary antibody 
(Sigma) diluted to 1 in 400 in 3% milk, 0.5% Tween, in PBS for 1 hour.  The blot was then 
washed once in PBS containing 0.5% Tween, washed 3 times in PBS, once in 0.3M NaCl 
in PBS for 30 minutes and once in distilled water for 15 minutes.  The blot was then 
developed using Enhanced Chemiluminescence reagents (Amersham, Bucks, UK). 
 
ASSAY OF GROWTH HORMONE SECRETION FROM PC12 CELLS 
For assay of growth hormone (GH) secretion from transfected cells [25, 26],  freshly 
trypsinized PC12 cells were plated out onto poly-D lysine-coated 24 well plates (VWR 
International, UK) at a density of 350,000 cells/well at 16-24 hours prior to transfection.  
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Cells were transfected using 100µl transfection reaction mixture consisting of 1µg 
control/test plasmid DNA, 1µg human Growth hormone (GH) plasmid, 3µl 
LipofectAMINE 2000 transfection reagent (Invitrogen, UK) per µg of plasmid DNA, made 
up to 100µl in opti-mem (Gibco, Paisley, UK).  The transfection mixture was incubated at 
room temperature for 30 minutes before being added drop wise to the cells.  The cells were 
then incubated for 4-6 hours at 37oC with the transfection reaction mixture before 
removing the transfection reaction mixture and replacing with growth media supplemented 
with 10µM CdCl2.  Cells were then maintained at 37oC, 5% CO2 for a further 48 hours 
before use in experiments. The secretion assay was performed on either permeabilised or 
intact cells depending upon the experiment.  In the case of the former, cells were washed 
once with KGEP buffer (20mM PIPES (pH 6.5), 139mM Kglutamate, 5mM EGTA, 2  mM 
ATP 2 mM  MgCl2) before permeabilisation with KGEP buffer containing 20µM digitonin 
(20mM PIPES (pH 6.5), 139mM Kglutamate, 5mM EGTA, 2  mM ATP 2 mM  
MgCl220µM digitonin) for 6 minutes.  Cells were stimulated by addition of 300µl of KGEP 
buffer containing no added CaCl2 or with CaCl2 added to give a calculated free Ca2+ 
concentration of 10µM and incubated for 15 minutes.  For experiments on intact cells, cells 
were washed with Krebs Ringer buffer and then stimulated by addition of 300µl of buffer 
with either 0 or 300µM ATP and incubated for 15 min at room temperature. After 
stimulation, supernatants were collected and stored  before lysis of the remaining adherent 
cells in distilled water containing 0.5% (v/v) Triton X-100 (300µl/well for 15 minutes) to 
give corresponding samples containing unsecreted growth hormone. GH was assayed 
following the manufacturer’s instructions in the hGH ELISA kit (Roche Diagnostics, 
Mannheim, Germany).  The levels of GH were calculated and secreted GH expressed as a 
percentage of total GH for each well. 
 
 
IMAGING OF INTRACELLULAR [Ca2+] IN PC12 CELLS 
For analysis of  changes in intracellular free  Ca2+ concentration ([Ca2+ ]i) in PC12 cells,  
the cells were plated onto collagen-coated glass coverslips (350,000 cells per well) and 
transfected with 2µg of control plasmid or 2µg of test plasmid using LipofectAMINE 2000 
reagent (Invitrogen) according to the manufacturer’s protocol.  48 hours after transfection, 
the cells were washed in Krebs-Ringer buffer and then incubated with 1µM X-rhod-1 AM 
(Molecular Probes Europe BV, Leiden, The Netherlands) in Krebs-Ringer buffer for 30 
minutes at room temperature.  Cells were washed in Krebs-Ringer buffer before imaging 
using laser-scanning confocal microscopy.  An ECFP image was taken prior to each 
experiment to allow distinction between transfected and untransfected cells.  X-rhod-1 was 
imaged using the Leica CS-SP-MP microscope with excitation at 543nm and light 
collection at 600-650nm.  The X-rhod-1 fluorescence was diffusely and uniformly 
distributed, suggesting cytosolic localization of the probe. Before and after the application 
of 300µM ATP as an agonist, fluorescence of X-rhod-1was monitored and fluorescence 
values for each cells expressed after normalisation to the initial fluorescence level for that 
cell (F/Fo). 
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RESULTS 
 
Plasmids were constructed encoding four KChIP isoforms (KChIP1.2, KChIP2.3, 
KChIP3.1 and KChIP4.1) with each KChIP prepared as C-terminal ECFP or N-terminal 
FLAG-tagged constructs. Since the terminology used for KChIP isoforms in the literature 
is inconsistent we have defined these by their accession number in the Materials and 
Methods but will refer to them henceforth as KChIP1-4 for simplicity. In order to validate 
the functionality of the constructs and to confirm that the fluorescently-tagged KChIPs 
behaved as expected for the wild-type proteins, we assessed their expression in cell lines 
and their ability to stimulate the traffic of Kv4.2 to the plasma membrane based on imaging 
of expressed Kv4.2 [15]. In initial studies using HeLa cells we successfully found cells 
expressing KChIPs 1, 2 or 4 but found poor survival of cells expressing KChIP3-ECFP, 
consistent with the reported apoptotic effect of KChIP3 expression in HeLa cells [27].  In 
contrast, all four KChIPs were expressed to the same extent in COS-7 cells (Figure 1A) 
and did not appear to affect cell survival. The four KChIPs expressed as ECFP fusion 
proteins had differing intracellular localisations consistent with previous results [14] with 
KChIP1 present on intracellular punctate structures as seen previously [15], KChIP2 being 
plasma membrane associated and KChIPs 3 and 4 being diffusely distributed throughout 
the cells (not shown).  As reported  [15], Kv4.2 when expressed alone trafficked poorly to 
the plasma membrane and accumulated in the Golgi complex (Figure 1B). In cells co-
transfected to express Kv4.2 along with one of the KChIP proteins, all the KChIPs co-
localised with Kv4.2 and importantly all four KChIPs stimulated the traffic of the channel 
to the plasma membrane with all of the KChIPs also being associated with the plasma 
membrane (Figure 1) demonstrating a similar functional ability of the four KChIP isoforms 
studied to interact with Kv4.2 as seen in other studies [6, 14]. 
 
PC12 cells are a neuronal/neuroendocrine model cell line widely used in the study of 
Ca2+ signalling and Ca2+-triggered secretion [28]. Over-expression of NCS-1 in these 
cells leads to increased secretion in response to agonist stimulation [29] via 
activation of phosphatidylinositol-4 kinase-IIIβ [30, 31]. Since KChIP3 has 
previously been shown to modify Ca2+ signalling in other cell types [32, 33] we 
aimed to examine the effect of over-expression of the KChIPs in PC12 cells using 
regulated secretion as an initial functional read out. All four KChIPs were expressed 
in PC12 cells following transfection (Figure 2A) although they had distinct 
intracellular localisations similar to that seen in COS7 cells (Figure 2B). KChIP1 
showed a punctate pattern of localisation, KChIP2 was primarily associated with the 
plasma membrane and KChIPs3 and 4 were diffusely distributed in the cytosol and 
the nucleus. From the western blot (Figure 2A), the various KChIPs appeared to be 
expressed at different levels in PC12 cells. We observed, however, that the numbers 
of cells expressing the constructs differed between the KChIPs. In order to ensure 
that individual transfected cells expressed the same levels of each of the KChIP-
ECFPs we quantified the average cellular fluorescence intensity of each of the 
expressed ECFP constructs taking into account total cellular fluorescence so that this 
would not be affected by differences in localisation. No differences were seen in 
overall cellular expression levels for the four KChIPs (Figure 2C). 
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To probe the effect of KChIP over-expression on secretion we made use of a well 
established assay in which cells were co-transfected so that they expressed human growth 
hormone (GH) as well as a test protein of choice. This approach is used so that only 
secretion from the small percentage (~5%) of transfected cells can be assayed. GH is not 
normally expressed by these cells but in transfected cells is packaged into dense core 
granules and secreted in response to Ca2+ elevation [26, 34] . This system was used to 
demonstrate a stimulatory effect on regulated secretion due to NCS-1 over-expression [29]. 
The PC12 cells were co-transfected to express GH and each of the KChIPs as FLAG-
tagged constructs. GH secretion was assayed under basal conditions and in response to 
activation of purinergic receptors following addition of 300µM ATP that primarily 
activates P2X receptors to stimulate secretion in these cells [35, 36].  None of the KChIPs 
significantly affected basal release of GH but expression of FLAG-KChIP3 specifically 
increased the amount of GH release due to ATP-stimulation (Figure 3A). The FLAG tag 
was at the N-terminus of the proteins where it would prevent myristoylation of KChIP1 
which is important for its membrane targeting [24].We also tested, therefore, the effect of 
transfection with untagged constructs in the pcDNA3 vector. In a comparison of KChIP1 
and 3 it was observed that again KChIP3 expression increased ATP-stimulated GH release 
but KChIP1 did not (Figure 3B). These results also show that the effect of KChIP3 was not 
affected by the presence of the FLAG tag. In addition, expression of KChIP3 tagged at the 
C-terminus with ECFP also increased GH release in response to ATP (see below). The 
magnitude of the increase in evoked GH release due to KChIP3 expression was similar to 
that previously seen with NCS-1 over-expression [29]. 
 
The effect of KChIP3 on GH secretion in PC12 cells could be due to a direct effect on the 
exocytotic machinery. If this was the case then secretion directly triggered by increasing 
Ca2+ concentration to a fixed level would also be affected by KChIP3 expression. 
Alternatively, the effect could result from alterations in the Ca2+ signal generated in 
response to ATP. This was tested by examining the effect of KChIP3 on GH release from 
cells permeabilised with digitonin and challenged with 0 or 10 µM free Ca2+  [26]. In cells 
expressing ECFP tagged KChIP3, GH release was increased following ATP stimulation of 
intact cells as seen before but unaffected in permeabilised cells (Figure 4) suggesting an 
indirect effect of KChIP3 expression on exocytosis. 
 
Over-expression of KChIP3 has been shown to result in an increase in the Ca2+ content of 
the ER [33] and to reduce the expression of one of the three [37] plasma membrane 
Na/Ca2+ exchangers NCX3 [32] . It is possible, therefore that the effect of KChIP3 on GH 
secretion could have been due to a modification in the Ca2+ signal following ATP 
stimulation. To find out if this was the case, and if any effect was specific for KChIP3, 
PC12 cells were transfected with each of the KChIPs tagged with ECFP, the cells loaded 
with the calcium indicator X-rhod-1 and changes in [Ca2+]i in response to ATP monitored 
[38]. Before and after stimulation, cellular fluorescence levels were monitored from high 
ECFP-expressing cells and adjacent control non-transfected cells and the data for 
expressing and non-transfected cells on the same coverslips directly compared. Expression 
of ECFP alone had no effect on the [Ca2+]i changes during ATP stimulation (data not 
shown). Expression of KChIPs1-4 had no significant effect on the peak increase in [Ca2+]i 
following ATP addition (Figure 5).  KChIPs 1,2 and 4 had no detectable effect on any 
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other aspect of the Ca2+ signal but KChIP3-ECFP resulted in a significantly elevated [Ca2+]i  
during later times as the Ca2+ concentration was slowly declining (Figure 5C).  
 
KChIP3 is known to interact with presenilin 1 and 2 and the presenilins have been shown 
to potentially affect [Ca2+ ]i through an effect on ER Ca2+ by having a Ca2+ leak function 
[39].  Presenilins are widely expressed [40] including in PC12 cells and, therefore, it was 
possible that the effect of KChIP3 on Ca2+ signals and secretion could have been due to an 
interaction with presenilin. To test this possibility we examined the effect of expression of 
presenilin-1 itself on [Ca2+]i and secretion and its effect of the enhancement of secretion by 
KChIP3. Cells were transfected to over-expression presenilin-1 using a presenilin-1-EGFP 
construct that has previously been shown to function like the wild –type protein [23]. 
Expression of presenilin-1-EGFP did not significantly modify the Ca2+ response to ATP 
stimulation (Figure 6A). In addition, presenilin-1-EGFP expression did not affect GH 
secretion (Figure 6B). We confirmed that co-transfection allowed the expression of both 
presenilin-1-EGFP and KChIP3-ECFP (Figure 6C). Expression of presenilin-1-EGFP had 
no effect on the stimulation of GH secretion due to KChIP3 expression (Figure 6D). These 
data did not, therefore, support an interaction between KChIP3 and presenilin underlying 
the effects on [Ca2+]i and secretion. Similarly we did not see any significant effect on GH 
secretion or the enhancement of secretion by KChIP3 in PC12 cells transfected to express 
Kv4.2 channels (data not shown). 
 
An alternative explanation for the effect of KChIP3 expression on reducing the decline of 
the Ca2+ transient would be by down-regulation of the NCX3 plasma membrane Na/Ca2+ 
exchanger. It has been shown that over-expression of wild-type or expression of a Ca2+-
insensitive and thus activated mutant of KChIP3 in SH-SY5Y cells results in suppression 
of transcription of NCX3 through DREAM activity while other NCX transporters are 
unaffected and expression of the mutant in cerebellar granule cells results in a slowing of 
the recovery of the [Ca2+]i  following a Ca2+  transient [32]. To test whether the specific 
effect of KChIP3 expression in PC12 cells could be explained by a reduction in NCX3 
expression we used immunofluorescence with specific antisera to determine the expression 
levels of endogenous NCX3 and NCX2 as a control in transfected cells in comparison to 
non-transfected cells on the same coverslips. No differences were seen in NCX2 levels 
under any conditions (Figure 7). For NCX3 no differences were observed for cells 
expressing KChIPs 1, 2 or 4 but in the case of KChIP3 the fluorescence intensity of 
expressing cells was seen to be lower than that of adjacent non-transfected cells (Figure 
7A). Quantification of the fluorescence indicated a specific reduction by KChIP3 of NCX3 
levels in transfected cells compared to non-transfected control cells (Figure 7B).  
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DISCUSSION 
From the study of the major known functions of the KChIPs no indications have so far 
emerged to suggest that they have specific physiological roles but rather have overlapping 
functions [41]. This is surprising given that the knock-out mice that have been studied for 
either KChIP2 or KChIP3 have observable phenotypes [9-11], indicating that the KChIPs 
cannot compensate for one another. One possibility is that KChIPs are non-redundant due 
to cell type-specific patterns of expression [21, 22]. Nevertheless, while the multiple 
KChIP isoforms have a common EF-hand containing domain they have distinct N-termini 
suggesting the possibility of distinct interactions and functions. We have now demonstrated 
a distinct effect of expression of KChIP3 compared to isoforms of KChIPs 1, 2 and 4 on 
Ca2+ responses to stimulation in PC12 cells that may be due to a specific effect on the 
expression of the NCX3 plasma membrane Na/Ca2+ exchanger and also have shown that 
this leads to specific physiological consequences in which KChIP3 but not KChIP1, 2 and 
4 can enhance stimulus evoked secretion. 
 
Previous work has shown effects of KChIP3 on Ca2+ signalling. In one case this was 
attributed to increased filling of ER Ca2+ stores [33]. The plasma membrane Na+/Ca2+ 
exchangers play crucial roles in the recovery of [Ca2+ ]i following  transient elevations [42]. 
Expression of an EF-hand mutant of KChIP3 (Ca2+-independent and thereby locked in an 
activating state) also resulted in a slowing of the recovery from a Ca2+ elevation in 
cerebellar granule cells [32]. This was attributed to a reduction in the levels of expression 
of the plasma membrane Na/Ca2+ exchanger NCX3 due to a direct repression of its 
transcription without effects on other exchangers NCX1 and NCX2.. This study also found 
that over-expression of wild-type KChIP3 in SH-SY5Y cells resulted in down regulation of 
NCX3. Consistent with these findings we found that expression of KChIP3 resulted in a 
down-regulation in the levels of NCX3 but not NCX2 in transfected PC12 cells. This 
finding provides an explanation for our observations on the effects of KChIP3 expression 
on the recovery of [Ca2+ ]i following a Ca2+  transient. 
.  
A stimulatory effect of KChIP3 was in response to agonist stimulation but was not seen in 
permeabilised cells in response to buffered Ca2+ concentration suggesting that the effect 
was most likely related to changes in Ca2+  signalling The changes in the Ca2+ signal in 
response to ATP in KChIP3 expressing cells provides an explanation for the increased 
secretion following stimulation. We can rule out effects of KChIP3 via Kv4 channels and 
also presenilin interactions. Traffic of Kv4 channels is stimulated by all four KChIPs but 
we saw no evidence that expression of Kv4.2 could influence exocytosis or the 
enhancement due to KChIP3. The interaction with presenilin has been described not only 
for KChIP3 [18] but also for KChIP4 [7] and their interactions have been suggested to 
modify aspects of Ca2+ signalling [43]. Our functional experiments did not, however, 
implicate a presenilin interaction in the KChIP3 effect on the Ca2+ response or secretion in 
PC12 cells. Expression of KChIP3 has been reported to trigger apoptosis in HeLa cells [27] 
but other KChIPs do not have this effect. Interestingly, in our initial experiments we found 
that that HeLa cells transfected with KChIP3 but not KChIPs 1, 2 and 4 failed to survive 
consistent with distinct physiological effects of these proteins. In other cell types such as 
PC12 and COS7 cells, KChIP3 does not appear to be apoptotic. There may be a link 
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between KChIP3-specific effects on intracellular Ca2+ as the pro-apoptotic effect of 
KChIP3 has been attributed to increased filling of EF Ca2+ stores [33].  
 
The down regulation of NCX3 but not NCX1 or NCX2 following expression of wild type 
or mutant KChIP3 in other cell types was ascribed to the DREAM transcriptional regulator 
function of the protein and indeed the NCX3 gene was found to harbour DRE motifs in its 
promoter region [32]. It is surprising therefore that we observed down-regulation of NCX3 
only as a consequence of KChIP3 expression and saw no effect of KChIP1 1,2 and 4 as the 
DREAM activity has been suggested to be shared by isoforms of all four KChIPs [20]. 
Indeed, it has been shown that the EF-hand containing core of KChIP3 is sufficient for 
Ca2+ -dependent binding to the DRE motif [44]. In addition, all four KChIPs were found to 
bind to DRE sites and to be equally efficient in repressing the transcription from three 
separate promoters [20]. In contrast, our data suggest that the KChIPs may differentially 
express this function depending on the cellular context. While this cannot be explained on 
the basis of expression levels it may be a consequence of the differential intracellular 
localisations of each of the proteins determined by elements in their variable N-terminal 
domains including motifs for myristoylation [24] and palmitoylation [45]. Further work 
will be required to determine the extent to which the DREAM activity in vivo is 
determined by KChIP3 alone.  Overall our findings suggest that the KChIP proteins may 
have a higher level of functional specialisation than had been appreciated and in particular 
that differences in KChIP3 levels may specifically exert modulatory effects on regulated 
secretion and possibly neurotransmission. 
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FIGURE LEGENDS 
 
Figure 1 Co-expression of KChIPs1-4 with Kv4.2 in COS-7 cells stimulates traffic of 
Kv4.2 to the plasma membrane.  
A. COS-7 cells were transfected to express KChIP1-4 as ECFP tagged constructs and 
expression of the proteins detected by western blotting with anti-GFP. B, COS-7 cells were 
transfected to express Kv4.2 and 48 hours after transfection the cells were fixed and 
channel localisation detected by immunostaining with anti-Kv4.2 antibody. C-D, COS-7 
cells were transfected to co-express Kv4.2 one of the KChIP-ECFPs as indicated and 
channel localisation detected by immunostaining with anti-Kv4.2. The colour overlays 
show the KChIP-ECFPs in green and Kv4.2 in red, with co-localisation seen in yellow. IN 
all cases traffic of the Kv4.2 to the plasma membrane was evident (arrowheads) along with 
KChIP localisation to the plasma membrane. The scale bar represents 10 µm. 
 
Figure 2.  Expression of KChIP-ECFPs in PC12 cells. 
A. PC12 cells were transfected to express KChIP1-4 as ECFP tagged constructs and 
expression of the proteins detected by western blotting with anti-GFP. B, PC12 cells were 
transfected to express KChIP1-4 as ECFP tagged constructs and live cells were imaged 48 
hours after transfection.  KChIP1 was localised to punctate structures, whilst KChIP2 was 
found predominantly on the plasma membrane and KChIPs 3 and 4 appeared to be mainly 
cytosolic and also present in the nucleus. The scale bar represents 10 µm. C. The average 
fluorescence intensity of cells expressing each of the four KChIPs (n=12-18) was 
determined under identical imaging conditions to compare expression levels. 
 
 
Figure 3 Expression of KChIP3 but none of the other KChIPs increases stimulated growth 
hormone release from PC12 cells. A. PC12 cells were transfected to express growth 
hormone (GH) and each one of the KChIPs as N-terminally FLAG-tagged constructs with 
the FLAG vector used as a control.  Two days after transfection the cells were washed in 
Krebs-Ringer buffer and incubated with no additions (Basal) or with 300µM ATP for 15 
minutes. Growth hormone release was assayed and expressed as a percentage of total 
cellular GH levels (n=4). B. PC12 cells were transfected to express growth hormone (GH) 
and KChIP1 or 3 in pcDNA3 as untagged constructs with the pcDNA vector used as a 
control.  Two days after transfection the cells were washed in Krebs-Ringer buffer and 
incubated with no additions (Basal) or with 300µM ATP for 15 minutes. Growth hormone 
release was assayed and expressed as a percentage of total cellular GH levels (n=9). 
 
Figure 4 KChIP3-ECFP increases stimulated release of growth hormone in intact but not in 
response to Ca2+ in permeabilised PC12 cells. 
A. PC12 cells were transfected to express growth hormone (GH) and KChIP3-ECFP with 
the ECFP vector used as a control.  Two days after transfection the cells were washed in 
Krebs-Ringer buffer and incubated with no additions (Basal) or with 300µM ATP for 15 
minutes. Growth hormone release was assayed and expressed as a percentage of total 
cellular GH levels (n=12). B. PC12 cells were transfected to express growth hormone (GH) 
and KChIP3-ECFP with the ECFP vector used as a control.  Two days after transfection 
the cells were washed, permeabilised with digitonin and incubated in the presence of 0 or 
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10 µM free Ca2+ for 15 minutes. Growth hormone release was assayed and expressed as a 
percentage of total cellular GH levels (n=6). 
 
Figure 5 Expression of KChIP-3 but not KChIP1, 2 or 4 delays the decline of intracellular 
free  Ca2+ concentration from the peak after stimulation with ATP. 
PC12 cells were transfected to express KChIPs1-4 as ECFP tagged constructs and 48 hours 
after transfection were loaded with X-rhod-1 AM and then live cells were imaged. An 
ECFP image was taken to allow identification of transfected and non-transfected cells and 
then X-rhod-1 fluorescence was monitored before stimulation and after stimulation by 
perfusion with 300µM ATP. Images of ECFP and X-rhod-1 before and at the peak after 
stimulation are shown.  After completion of the experiment average values were collected 
for whole cell fluorescence for transfected and adjacent control cells. Fluorescence values 
were normalised to the initial fluorescence for each cell and the data are shown as mean + 
SEM. The numbers of cells for each condition were as follows: KChIP1, 19 control, 17 
transfected; KChIP2, 35 control, 29 transfected; KChIP3, 19 control, 21 transfected; 
KChIP4, 22 control, 22 transfected. * indicates time points at which the values for 
KChIP3-ECFP transfected cells were significantly different from control values based on 
use of a Students’ t-test with p values less than 0.05. 
 
Figure 6 Expression of presenilin-1-EGFP has no effect on Ca2+ concentration after 
stimulation with ATP or on growth hormone release from PC12 cells. 
A. PC12 cells were transfected to express presenilin-1-EGFP (PS1-EGFP) and 48 hours 
after transfection were loaded with X-rhod-1 AM and then live cells were imaged. An 
EGFP image was taken to allow identification of transfected and non-transfected cells and 
then X-rhod-1 fluorescence was monitored before and after stimulation by perfusion with 
300µM ATP. Images of EGFP and X-rhod-1 before stimulation and at the peak after 
stimulation are shown.  After completion of the experiment average values were collected 
for whole cell fluorescence for transfected and adjacent control cells. Fluorescence values 
were normalised to the initial fluorescence for each cell and the data are shown as mean + 
SEM. The numbers of cells for each condition were 28 for control  and for 26 transfected 
conditions B. PC12 cells were transfected to express growth hormone (GH) and presenilin-
1-EGFP (PS1-EGFP) with the ECFP vector used as a control (n=18).  Two days after 
transfection the cells were washed in Krebs-Ringer buffer and incubated with no additions 
(Basal) or with 300µM ATP for 15 minutes. Growth hormone release was assayed and 
expressed as a percentage of total cellular GH levels. C. PC12 cells were transfected to 
express KChIP3 alone (a), presenilin-1-EGFP alone (b) or both proteins (c,c’). D. PC12 
cells were transfected to express growth hormone (GH) and KChIP3-ECFP alone or in 
combination with presenilin-1-EGFP (n=12).  Two days after transfection the cells were 
washed in Krebs-Ringer buffer and incubated with no additions (Basal) or with 300µM 
ATP for 15 minutes. Growth hormone release was assayed and expressed as a percentage 
of total cellular GH levels. 
 
Figure 7. Effect of KChIP expression on the levels of NCX2 and NCX3 Na/Ca2+ 
exchangers. A. PC12 cells were transfected to express KChIP-ECFP constructs as 
indicated, fixed and stained with anti-NCX2 or NCX3. Microscope fields were examined 
that contained both transfected cells and non-transfected cells as seen in the ECFP images. 
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Cells transfected with KChIP3-ECFP showing lower NCX3 immunofluorescence levels 
are indicated by arrows. The scale bar represents 10 µm. B. Fluorescence levels from 
transfected and adjacent control non-transfected cells were determined (n=12) and the 
values for transfected cells were expressed as a percentage of the appropriate controls. * 
p<0.001 compared to non-transfected control cells. 
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